Clicky

Friday, November 20, 2026
All public companies · Official EDGAR

CADLCandel Therapeutics, Inc.

Nasdaq · CIK 0001841387
Filer category<br>Emerging growth company
Entity typeoperating
SIC2836 Biological Products, (No Diagnostic Substances)
FY end1231
XBRL facts221

Identity from submissions API

NameCandel Therapeutics, Inc.
CIK0001841387
TickersCADL
ExchangesNasdaq
Entity typeoperating
Category<br>Emerging growth company
SIC2836 Biological Products, (No Diagnostic Substances)
EIN522214851
LEI—
Fiscal year end1231
State of incorporationDE DE
Phone617-916-5445
Website—
Investor website—
Owner org03 Life Sciences
Flags—
Description—
Insider transactions (issuer)1
Insider transactions (owner)0

Former names

  • None listed.
Business address
117 KENDRICK STREET
SUITE 450
NEEDHAM
MA
02494
MA
Mailing address
117 KENDRICK STREET
SUITE 450
NEEDHAM
MA
02494
MA

EDGAR has no company-logo API. Website field is shown when the filer provided one.

Financialist coverage

SEC filings

423 filing rows loaded from submissions recent.

FiledFormDocumentItemsAccessionFile no.FilmActSizeXBRLiXBRL
2026-11-16 SCHEDULE 13G/A xslSCHEDULE_13G_X02/primary_doc.xml 0001493215-26-000186 005-93359 261555573 34 10540
2026-11-12 8-K 8-K 8.01,9.01 0001193125-26-458522 001-40629 261547456 34 423500 1 1
2026-11-12 424B5 424B5 0001193125-26-458505 333-289595 261547377 33 558892
2026-11-12 10-Q 10-Q 0001193125-26-458380 001-40629 261547027 34 10830866 1 1
2026-11-12 8-K 8-K 2.02,9.01 0001193125-26-458316 001-40629 261546771 34 377806 1 1
2026-11-05 4 4 0001193125-26-449949 5667
2026-11-05 3 3 0001193125-26-449933 16417
2026-10-02 4 4 0001193125-26-412658 5475
2026-10-02 4 4 0001193125-26-412655 5475
2026-10-02 4 4 0001193125-26-412654 5441
2026-09-11 4 4 0001873905-26-000002 11139
2026-09-10 144 xsl144X01/primary_doc.xml 0001950047-26-009295 001-40629 261371589 33 6306
2026-09-10 4 4 0001193125-26-387924 5571
2026-09-10 3 3 0001193125-26-387919 15875
2026-09-10 8-K 8-K 5.02,7.01,9.01 0001193125-26-387310 001-40629 261369696 34 231762 1 1
2026-09-09 8-K 8-K 7.01,9.01 0001193125-26-386561 001-40629 261368722 34 31670041 1 1
2026-08-19 4 4 0001923794-26-000004 4913
2026-08-17 144 xsl144X01/primary_doc.xml 0001950047-26-008263 001-40629 261287184 33 5769
2026-08-13 10-Q 10-Q 0001193125-26-347980 001-40629 261270200 34 11207012 1 1
2026-08-13 8-K 8-K 2.02,9.01 0001193125-26-347957 001-40629 261270157 34 371103 1 1
2026-07-27 SCHEDULE 13G xslSCHEDULE_13G_X02/primary_doc.xml 0002012383-26-002278 005-93359 261206147 34 10952
2026-07-08 4 4 0002139479-26-000004 5665
2026-07-08 3 3 0002139479-26-000003 15725
2026-07-01 4 4 0001909680-26-000002 5444
2026-07-01 4 4 0001923794-26-000002 5442
2026-07-01 4 4 0001494695-26-000018 5483
2026-07-01 4 4 0001242215-26-000018 5517
2026-07-01 4 4 0001979825-26-000006 5517
2026-06-29 144 xsl144X01/primary_doc.xml 0001950047-26-006607 001-40629 261136426 33 4891
2026-06-29 144 xsl144X01/primary_doc.xml 0001950047-26-006597 001-40629 261136388 33 5054
2026-06-24 4 4 0002013423-26-000004 5857
2026-06-24 4 4 0001979825-26-000004 5842
2026-06-24 4 4 0001242215-26-000016 5839
2026-06-24 4 4 0001691160-26-000002 5845
2026-06-24 4 4 0001873465-26-000002 5849
2026-06-24 4 4 0001742428-26-000004 5818
2026-06-24 4 4 0001867450-26-000002 5828
2026-06-24 4 4 0001814338-26-000004 5822
2026-06-24 4 4 0001494695-26-000015 5805
2026-06-24 8-K 8-K 5.07 0001841387-26-000009 001-40629 261116157 34 176736 1 1
2026-06-16 8-K 8-K 5.02,9.01 0001841387-26-000007 001-40629 261094938 34 369871 1 1
2026-05-15 8-K 8-K 7.01,9.01 0001193125-26-226751 001-40629 26987561 34 3157001 1 1
2026-05-15 SCHEDULE 13G xslSCHEDULE_13G_X02/primary_doc.xml 0001493215-26-000094 005-93359 26982432 34 12678
2026-05-14 10-Q 10-Q 0001193125-26-222904 001-40629 26975989 34 9842789 1 1
2026-05-14 8-K 8-K 2.02,9.01 0001193125-26-222892 001-40629 26975967 34 332663 1 1
2026-04-29 ARS ARS 0001841387-26-000005 001-40629 26916152 34 2009800
2026-04-29 DEFA14A DEFA14A 0001841387-26-000004 001-40629 26916055 34 3739749
2026-04-29 DEF 14A DEF 14A 0001193125-26-191506 001-40629 26915845 34 5038833 1 1
2026-04-27 SCHEDULE 13G/A xslSCHEDULE_13G_X02/primary_doc.xml 0002012383-26-001737 005-93359 26901080 34 11003
2026-04-02 4 4 0001494695-26-000007 5481
2026-04-02 4 4 0001242215-26-000010 5515
2026-04-02 4 4 0001979825-26-000002 5515
2026-03-18 SCHEDULE 13D/A xslSCHEDULE_13D_X02/primary_doc.xml 0001494695-26-000005 005-93359 26769418 34 14045
2026-03-12 S-8 S-8 0001193125-26-103186 333-294230 26745822 33 227829 1 1
2026-03-12 10-K 10-K 0001193125-26-103134 001-40629 26745743 34 14539210 1 1
2026-03-12 8-K 8-K 2.02,9.01 0001193125-26-103126 001-40629 26745734 34 355490 1 1
2026-02-26 4 4 0001193125-26-078246 6928
2026-02-23 8-K 8-K 1.01,8.01,9.01 0001193125-26-062490 001-40629 26662134 34 479932 1 1
2026-02-20 424B5 424B5 0001193125-26-061389 333-289595 26660137 33 591729
2026-02-19 424B5 424B5 0001193125-26-059514 333-289595 26654948 33 593473
2026-02-19 8-K 8-K 1.01,2.02,7.01,8.01,9.01 0001193125-26-059334 001-40629 26654237 34 226376 1 1
2026-01-28 4 4 0001193125-26-027412 5533
2026-01-28 4 4 0001193125-26-027409 5644
2026-01-28 4 4 0001193125-26-027406 5488
2026-01-28 4 4 0001193125-26-027396 5525
2026-01-28 4 4 0001193125-26-027392 5533
2026-01-21 SCHEDULE 13G xslSCHEDULE_13G_X01/primary_doc.xml 0002012383-26-000746 005-93359 26545935 34 10862
2025-12-05 8-K 8-K 7.01,9.01 0001193125-25-308719 001-40629 251551239 34 32117065 1 1
2025-11-13 10-Q 10-Q 0001193125-25-279086 001-40629 251475598 34 10304092 1 1
2025-11-13 8-K 8-K 2.02,9.01 0001193125-25-279072 001-40629 251475553 34 372983 1 1
2025-10-14 8-K 8-K 1.01,2.02,2.03,3.02,7.01,8.01,9.01 0001193125-25-238254 001-40629 251389860 34 1562590 1 1
2025-08-22 EFFECT xslEFFECTX01/primary_doc.xml ,, 9999999995-25-002727 333-289595 251247806 33 1878
2025-08-21 8-K 8-K 1.01,9.01 0000950170-25-110682 001-40629 251241231 34 241116 1 1
2025-08-20 CORRESP filename1.htm 0001193125-25-184067 6792
2025-08-20 UPLOAD filename1.pdf 0000000000-25-008857 333-289595 40244
2025-08-14 S-3 S-3 0001193125-25-180411 333-289595 251214604 33 1537883 1 1
2025-08-14 10-Q 10-Q 0000950170-25-108450 001-40629 251214495 34 10093284 1 1
2025-08-14 8-K 8-K 2.02,9.01 0000950170-25-108448 001-40629 251214485 34 363418 1 1
2025-07-30 4 4 0000950170-25-100320 8679
2025-07-02 4 4 0000950170-25-093035 8679
2025-06-30 144 xsl144X01/primary_doc.xml 0001950047-25-004691 001-40629 251092303 33 5242
2025-06-30 SCHEDULE 13G xslSCHEDULE_13G_X01/primary_doc.xml 0001636587-25-000035 005-93359 251089162 34 12446
2025-06-26 4 4 0000950170-25-090199 4825
2025-06-26 4 4 0000950170-25-090198 4819
2025-06-26 4 4 0000950170-25-090197 7164
2025-06-26 4 4 0000950170-25-090196 7006
2025-06-26 4 4 0000950170-25-090195 4760
2025-06-26 4 4 0000950170-25-090193 4780
2025-06-26 4 4 0000950170-25-090192 4746
2025-06-26 4 4 0000950170-25-090194 4826
2025-06-26 4 4 0000950170-25-090191 5824
2025-06-24 4 4 0000950170-25-089473 5526
2025-06-24 8-K 8-K 1.01,7.01,9.01 0001193125-25-145405 001-40629 251066920 34 338122 1 1
2025-06-24 424B5 424B5 0001193125-25-145401 333-266605 251066907 33 515036
2025-06-23 8-K 8-K 5.02,7.01,9.01 0001193125-25-144204 001-40629 251063018 34 176516 1 1
2025-06-18 4 4 0000950170-25-087708 5708
2025-06-18 4 4 0000950170-25-087705 5675
2025-06-18 4 4 0000950170-25-087703 5705
2025-06-18 4 4 0000950170-25-087702 5668
2025-06-18 4 4 0000950170-25-087700 5712
2025-06-18 4 4 0000950170-25-087699 5691
2025-06-18 4 4 0000950170-25-087698 5685
2025-06-18 4 4 0000950170-25-087697 5702
2025-06-18 8-K 8-K 5.07 0000950170-25-087696 001-40629 251055229 34 174192 1 1
2025-06-06 4 4 0000950170-25-083163 5399
2025-06-06 3 3 0000950170-25-083136 14904
2025-06-06 8-K 8-K 5.02,7.01,9.01 0000950170-25-082705 001-40629 251028934 34 222906 1 1
2025-05-28 8-K 8-K 7.01,8.01,9.01 0000950170-25-078079 001-40629 25991206 34 240094 1 1
2025-05-22 8-K 8-K 7.01,9.01 0000950170-25-076458 001-40629 25978230 34 253122 1 1
2025-05-15 SCHEDULE 13G/A xslSCHEDULE_13G_X01/primary_doc.xml 0001104659-25-049512 005-93359 25954265 34 16238
2025-05-13 10-Q 10-Q 0000950170-25-069833 001-40629 25937352 34 8851944 1 1
2025-05-13 8-K 8-K 2.02,9.01 0000950170-25-069826 001-40629 25937285 34 352372 1 1
2025-04-29 ARS ARS 0000950170-25-060171 001-40629 25888012 34 1597873
2025-04-29 DEFA14A DEFA14A 0000950170-25-060112 001-40629 25887456 34 3745431
2025-04-29 DEF 14A DEF 14A 0000950170-25-060093 001-40629 25887108 34 1952153 1 1
2025-04-23 8-K 8-K 7.01,9.01 0000950170-25-057398 001-40629 25861675 34 252462 1 1
2025-03-27 8-K 8-K 7.01,8.01,9.01 0001193125-25-064374 001-40629 25774965 34 20659664 1 1
2025-03-20 4 4 0000950170-25-042728 13385
2025-03-20 4 4 0000950170-25-042726 9103
2025-03-20 4 4 0000950170-25-042725 6954
2025-03-20 4/A 4/A 0000950170-25-042724 9490
2025-03-19 4 4 0000950170-25-042002 7705
2025-03-19 4 4 0000950170-25-041991 5309
2025-03-18 144 xsl144X01/primary_doc.xml 0001950047-25-002014 001-40629 25748847 33 6887
2025-03-18 144 xsl144X01/primary_doc.xml 0001950047-25-002013 001-40629 25748842 33 6943
2025-03-18 144 xsl144X01/primary_doc.xml 0001950047-25-002010 001-40629 25748828 33 7176
2025-03-17 144 xsl144X01/primary_doc.xml 0001950047-25-001943 001-40629 25744914 33 6892
2025-03-17 144 xsl144X01/primary_doc.xml 0001950047-25-001942 001-40629 25744909 33 7017
2025-03-13 S-8 S-8 0001193125-25-053987 333-285794 25736515 33 69693
2025-03-13 10-K 10-K 0000950170-25-038803 001-40629 25736279 34 12420327 1 1
2025-03-13 8-K 8-K 2.02,9.01 0000950170-25-038757 001-40629 25735938 34 379423 1 1
2025-02-25 4 PRIMARY DOCUMENT 0001873919-25-000002 9885
2025-02-25 8-K 8-K 7.01,8.01,9.01 0000950170-25-026100 001-40629 25659508 34 277098 1 1
2025-02-14 SCHEDULE 13G/A xslSCHEDULE_13G_X01/primary_doc.xml 0001415889-25-004195 005-93359 25631274 34 13395
2025-02-14 4 4 0000950170-25-021287 5537
2025-02-14 4 4 0000950170-25-021284 17771
2025-02-14 4 4 0000950170-25-021292 17644
2025-02-14 4 4 0000950170-25-021283 17592
2025-02-14 4 4 0000950170-25-021282 17647
2025-02-14 SCHEDULE 13G xslSCHEDULE_13G_X01/primary_doc.xml 0001104659-25-014091 005-93359 25628866 34 20577
2025-02-13 4 PRIMARY DOCUMENT 0001873919-25-000001 8983
2025-02-07 SCHEDULE 13G/A xslSCHEDULE_13G_X01/primary_doc.xml 0001649553-25-000036 005-93359 25601775 34 11158
2025-02-07 SCHEDULE 13G/A xslSCHEDULE_13G_X01/primary_doc.xml 0000315066-25-000411 005-93359 25599815 34 11709
2025-02-07 SCHEDULE 13G xslSCHEDULE_13G_X01/primary_doc.xml 0000315066-25-000400 005-93359 25599757 34 11552
2025-01-17 4 4 0000950170-25-006726 5134
2025-01-17 4 4 0000950170-25-006733 5133
2025-01-17 4 4 0000950170-25-006725 5131
2025-01-17 4 4 0000950170-25-006724 5126
2025-01-17 4 4 0000950170-25-006723 5244
2025-01-15 144 xsl144X01/primary_doc.xml 0000950170-25-005640 001-40629 25531233 33 4851
2025-01-15 144 xsl144X01/primary_doc.xml 0000950170-25-005639 001-40629 25531232 33 4965
2025-01-15 144 xsl144X01/primary_doc.xml 0000950170-25-005638 001-40629 25531231 33 4850
2025-01-15 144 xsl144X01/primary_doc.xml 0000950170-25-005637 001-40629 25531230 33 4804
2025-01-15 144 xsl144X01/primary_doc.xml 0000950170-25-005636 001-40629 25531229 33 4898
2025-01-13 8-K 8-K 2.02,7.01,8.01,9.01 0000950170-25-004581 001-40629 25524906 34 290237 1 1
2025-01-10 4 4 0000950170-25-004200 5135
2025-01-10 4 4 0000950170-25-004199 5132
2025-01-10 4 4 0000950170-25-004198 5127
2025-01-10 4 4 0000950170-25-004197 5135
2025-01-10 4 4 0000950170-25-004195 5245
2025-01-08 144 xsl144X01/primary_doc.xml 0000950170-25-003301 001-40629 25516656 33 4851
2025-01-08 144 xsl144X01/primary_doc.xml 0000950170-25-003300 001-40629 25516655 33 4899
2025-01-08 144 xsl144X01/primary_doc.xml 0000950170-25-003299 001-40629 25516654 33 4966
2025-01-08 144 xsl144X01/primary_doc.xml 0000950170-25-003298 001-40629 25516653 33 4848
2025-01-08 144 xsl144X01/primary_doc.xml 0000950170-25-003297 001-40629 25516652 33 4804
2024-12-30 4 PRIMARY DOCUMENT 0001873919-24-000011 12985
2024-12-26 4 PRIMARY DOCUMENT 0001873919-24-000010 16084
2024-12-18 4 4 0000950170-24-137889 7875
2024-12-17 SC 13G SC 13G 0001104659-24-129285 005-93359 241554350 34 63599
2024-12-13 4 PRIMARY DOCUMENT 0001873919-24-000009 12991
2024-12-13 8-K 8-K 1.01,8.01,9.01 0001193125-24-278717 001-40629 241549495 34 602244 1 1
2024-12-13 424B5 424B5 0001193125-24-278628 333-266605 241548940 33 586612
2024-12-12 424B5 424B5 0001193125-24-277171 333-266605 241545591 33 587760
2024-12-11 8-K 8-K 7.01,8.01,9.01 0001193125-24-274870 001-40629 241540151 34 16478951 1 1
2024-12-06 4 PRIMARY DOCUMENT 0001873919-24-000008 11991
2024-12-03 4 4 0000950170-24-132932 5136
2024-12-03 4 4 0000950170-24-132930 5128
2024-12-03 4 4 0000950170-24-132928 5247
2024-12-03 4 4 0000950170-24-132925 5136
2024-11-29 144 xsl144X01/primary_doc.xml 0000950170-24-131713 001-40629 241513452 33 4850
2024-11-29 144 xsl144X01/primary_doc.xml 0000950170-24-131712 001-40629 241513436 33 4900
2024-11-29 144 xsl144X01/primary_doc.xml 0000950170-24-131711 001-40629 241513415 33 4968
2024-11-29 144 xsl144X01/primary_doc.xml 0000950170-24-131710 001-40629 241513414 33 4851
2024-11-27 4 PRIMARY DOCUMENT 0001873919-24-000006 9088
2024-11-21 4 4 0000950170-24-129677 6889
2024-11-14 10-Q 10-Q 0000950170-24-126767 001-40629 241457384 34 7905198 1 1
2024-11-14 8-K 8-K 2.02,9.01 0000950170-24-126759 001-40629 241457341 34 336771 1 1
2024-11-08 4 PRIMARY DOCUMENT 0001873919-24-000005 16182
2024-11-01 4 PRIMARY DOCUMENT 0001873919-24-000004 16376
2024-10-28 4 PRIMARY DOCUMENT 0001873919-24-000003 13469
2024-10-28 8-K 8-K 7.01,8.01,9.01 0000950170-24-117578 001-40629 241398500 34 255632 1 1
2024-10-15 4 PRIMARY DOCUMENT 0001873919-24-000002 12011
2024-10-03 4 PRIMARY DOCUMENT 0001873919-24-000001 12002
2024-09-23 144 xsl144X01/primary_doc.xml 0001972362-24-001370 001-40629 241317024 33 5064
2024-09-13 144 xsl144X01/primary_doc.xml 0001972362-24-001348 001-40629 241298869 33 4410
2024-08-13 10-Q 10-Q 0000950170-24-095784 001-40629 241198923 34 7846766 1 1
2024-08-13 8-K 8-K 2.02,9.01 0000950170-24-095775 001-40629 241198877 34 326464 1 1
2024-07-19 4 4 0000950170-24-084762 5136
2024-07-19 4 4 0000950170-24-084761 5128
2024-07-19 4 4 0000950170-24-084760 5133
2024-07-19 4 4 0000950170-24-084759 5247
2024-07-19 4 4 0000950170-24-084758 5136
2024-07-17 144 xsl144X01/primary_doc.xml 0000950170-24-084066 001-40629 241120963 33 4851
2024-07-17 144 xsl144X01/primary_doc.xml 0000950170-24-084065 001-40629 241120961 33 4900
2024-07-17 144 xsl144X01/primary_doc.xml 0000950170-24-084063 001-40629 241120955 33 4805
2024-07-17 144 xsl144X01/primary_doc.xml 0000950170-24-084062 001-40629 241120954 33 4966
2024-07-17 144 xsl144X01/primary_doc.xml 0000950170-24-084061 001-40629 241120952 33 4851
2024-07-15 4 4 0000950170-24-083403 5136
2024-07-15 4 4 0000950170-24-083401 5128
2024-07-15 4 4 0000950170-24-083399 5133
2024-07-15 4 4 0000950170-24-083397 5246
2024-07-15 4 4 0000950170-24-083396 5136
2024-07-11 144 xsl144X01/primary_doc.xml 0000950170-24-082857 001-40629 241111045 33 4851
2024-07-11 144 xsl144X01/primary_doc.xml 0000950170-24-082856 001-40629 241111042 33 4900
2024-07-11 144 xsl144X01/primary_doc.xml 0000950170-24-082855 001-40629 241111039 33 4805
2024-07-11 144 xsl144X01/primary_doc.xml 0000950170-24-082854 001-40629 241111036 33 4966
2024-07-11 144 xsl144X01/primary_doc.xml 0000950170-24-082853 001-40629 241111035 33 4851
2024-06-28 8-K 8-K 5.07 0000950170-24-078795 001-40629 241081575 34 183497 1 1
2024-06-27 4 4 0000950170-24-078175 5709
2024-06-27 4 4 0000950170-24-078174 5713
2024-06-27 4 4 0000950170-24-078173 5698
2024-06-27 4 4 0000950170-24-078172 5719
2024-06-27 4 4 0000950170-24-078171 5675
2024-06-27 4 4 0000950170-24-078170 5712
2024-06-27 4 4 0000950170-24-078169 5682
2024-06-27 4 4 0000950170-24-078168 5715
2024-05-30 ARS ARS 0001193125-24-150516 001-40629 241006688 34 4315741
2024-05-30 DEF 14A DEF 14A 0001193125-24-150379 001-40629 241005916 34 684339
2024-05-30 8-K 8-K 5.03,9.01 0000950170-24-066608 001-40629 241005594 34 184945 1 1
2024-05-24 424B5 424B5 0001193125-24-146526 333-266605 24980804 33 16077
2024-05-23 8-K 8-K 7.01,8.01,9.01 0000950170-24-064022 001-40629 24979512 34 335944 1 1
2024-05-14 10-Q 10-Q 0000950170-24-059118 001-40629 24941562 34 7707213 1 1
2024-05-14 8-K 8-K 2.02,9.01 0000950170-24-059109 001-40629 24941543 34 363110 1 1
2024-04-25 8-K 8-K 7.01,9.01 0000950170-24-047941 001-40629 24873140 34 237790 1 1
2024-04-25 10-K/A 10-K/A 0001193125-24-111564 001-40629 24872984 34 640116 1 1
2024-04-11 8-K 8-K 7.01,8.01,9.01 0000950170-24-043532 001-40629 24837238 34 229072 1 1
2024-04-09 8-K 8-K 7.01,8.01,9.01 0000950170-24-042800 001-40629 24831212 34 224926 1 1
2024-04-04 8-K 8-K 7.01,8.01,9.01 0000950170-24-041619 001-40629 24821722 34 270456 1 1
2024-03-28 S-8 S-8 0001193125-24-079759 333-278294 24793642 33 79163
2024-03-28 10-K 10-K 0000950170-24-037637 001-40629 24793609 34 10108212 1 1
2024-03-28 8-K 8-K 2.02,9.01 0000950170-24-037624 001-40629 24793555 34 392218 1 1
2024-03-06 8-K 8-K 7.01,9.01 0000950170-24-026877 001-40629 24724394 34 225864 1 1
2024-02-13 424B5 424B5 0001193125-24-032997 333-266605 24622829 33 18137
2024-02-13 8-K 8-K 7.01,8.01,9.01 0000950170-24-014191 001-40629 24622627 34 234456 1 1
2024-01-19 3 3 0000950170-24-005586 18258
2024-01-12 8-K 8-K 5.02 0000950170-24-004262 001-40629 24532390 34 164379 1 1
2024-01-03 8-K 8-K 8.01 0000950170-24-000539 001-40629 24504418 34 164190 1 1
2023-12-15 8-K 8-K 5.02 0000950170-23-070509 001-40629 231488364 34 165510 1 1
2023-12-12 8-K 8-K 7.01,9.01 0000950170-23-069533 001-40629 231480051 34 236275 1 1
2023-11-30 4 FORM 4 SUBMISSION 0001209191-23-056985 4973
2023-11-30 4 FORM 4 SUBMISSION 0001209191-23-056987 4966
2023-11-30 4 FORM 4 SUBMISSION 0001209191-23-056986 5084
2023-11-30 4 FORM 4 SUBMISSION 0001209191-23-056982 4973
2023-11-30 4 FORM 4 SUBMISSION 0001209191-23-056981 4878
2023-11-28 4 FORM 4 SUBMISSION 0001209191-23-056801 5165
2023-11-28 4 FORM 4 SUBMISSION 0001209191-23-056803 5172
2023-11-28 4 FORM 4 SUBMISSION 0001209191-23-056804 5282
2023-11-28 4 FORM 4 SUBMISSION 0001209191-23-056806 5172
2023-11-28 4 FORM 4 SUBMISSION 0001209191-23-056802 5077
2023-11-28 8-K 8-K 2.05,9.01 0000950170-23-066248 001-40629 231442037 34 245656 1 1
2023-11-21 8-K 8-K 3.01 0000950170-23-065567 001-40629 231429011 34 165884 1 1
2023-11-09 10-Q 10-Q 0000950170-23-061566 001-40629 231390216 34 9393030 1 1
2023-11-09 8-K 8-K 2.02,9.01 0000950170-23-061558 001-40629 231390186 34 422235 1 1
2023-11-06 8-K 8-K 7.01,8.01,9.01 0000950170-23-059042 001-40629 231378492 34 246256 1 1
2023-11-06 8-K 8-K 7.01,8.01,9.01 0000950170-23-059024 001-40629 231378192 34 276866 1 1
2023-10-18 8-K 8-K 7.01,9.01 0000950170-23-053894 001-40629 231331329 34 266340 1 1
2023-09-26 8-K 8-K 7.01,9.01 0000950170-23-049798 001-40629 231277236 34 268108 1 1
2023-08-10 10-Q 10-Q 0000950170-23-040984 001-40629 231157342 34 10528073 1 1
2023-08-10 8-K 8-K 2.02,9.01 0000950170-23-040980 001-40629 231157279 34 512675 1 1
2023-06-29 4 FORM 4 SUBMISSION 0001209191-23-040136 5832
2023-06-29 4 FORM 4 SUBMISSION 0001209191-23-040135 5863
2023-06-29 4 FORM 4 SUBMISSION 0001209191-23-040134 5825
2023-06-29 4 FORM 4 SUBMISSION 0001209191-23-040137 5869
2023-06-29 4 FORM 4 SUBMISSION 0001209191-23-040133 5865
2023-06-29 4 FORM 4 SUBMISSION 0001209191-23-040132 5842
2023-06-29 4 FORM 4 SUBMISSION 0001209191-23-040131 5841
2023-06-29 4 FORM 4 SUBMISSION 0001209191-23-040130 5848
2023-06-29 8-K 8-K 5.07 0000950170-23-030542 001-40629 231054400 34 219362 1 1
2023-06-13 8-K 8-K 7.01,9.01 0000950170-23-027591 001-40629 231010286 34 258318 1 1
2023-06-09 4 FORM 4 SUBMISSION 0001209191-23-035623 5541
2023-06-09 3 FORM 3 SUBMISSION 0001209191-23-035621 7664
2023-06-08 8-K 8-K 5.02,9.01 0000950170-23-026913 001-40629 231000767 34 253630 1 1
2023-05-23 ARS ARS 0000950170-23-023538 001-40629 23946550 34 5224415
2023-05-23 DEF 14A DEF 14A 0001193125-23-151141 001-40629 23946548 34 656449
2023-05-19 8-K 8-K 7.01,8.01,9.01 0000950170-23-023163 001-40629 23938049 34 12549958 1 1
2023-05-11 10-Q 10-Q 0000950170-23-020873 001-40629 23909057 34 9252433 1 1
2023-05-11 8-K 8-K 2.02,9.01 0000950170-23-020869 001-40629 23909009 34 440952 1 1
2023-05-09 8-K 8-K 5.08,9.01 0000950170-23-019831 001-40629 23903151 34 186135 1 1
2023-05-02 4 FORM 4 SUBMISSION 0001209191-23-026581 6372
2023-05-02 4 FORM 4 SUBMISSION 0001209191-23-026574 5684
2023-05-02 4 FORM 4 SUBMISSION 0001209191-23-026569 5787
2023-05-02 4 FORM 4 SUBMISSION 0001209191-23-026549 5685
2023-05-02 4 FORM 4 SUBMISSION 0001209191-23-026542 5590
2023-05-01 10-K/A 10-K/A 0001193125-23-128783 001-40629 23870094 34 879901 1 1
2023-04-17 8-K 8-K 7.01,9.01 0000950170-23-012985 001-40629 23822918 34 354714 1 1
2023-03-30 S-8 S-8 0001193125-23-084634 333-270967 23777359 33 66138
2023-03-30 10-K 10-K 0000950170-23-010760 001-40629 23777313 34 12435003 1 1
2023-03-30 8-K 8-K 2.02,9.01 0000950170-23-010758 001-40629 23777274 34 462634 1 1
2023-02-22 8-K 8-K 7.01 0001193125-23-044239 001-40629 23650666 34 150180 1 1
2023-02-17 4/A FORM 4/A SUBMISSION 0000899243-23-005523 9238
2023-02-09 SC 13G/A filing.txt 0000315066-23-001486 005-93359 23601787 34 8243
2022-12-12 4 FORM 4 SUBMISSION 0001209191-22-060700 5212
2022-12-12 4 FORM 4 SUBMISSION 0001209191-22-060694 11712
2022-12-12 4 FORM 4 SUBMISSION 0001209191-22-060693 7182
2022-12-12 4 FORM 4 SUBMISSION 0001209191-22-060689 7230
2022-12-12 4 FORM 4 SUBMISSION 0001209191-22-060692 7236
2022-12-12 4 FORM 4 SUBMISSION 0001209191-22-060691 7139
2022-12-06 8-K 8-K 8.01,9.01 0000950170-22-026104 001-40629 221448570 34 297759 1 1
2022-12-06 8-K 8-K 7.01,9.01 0001193125-22-298918 001-40629 221446722 34 35445769 1 1
2022-11-30 4 FORM 4 SUBMISSION 0000899243-22-037232 5047
2022-11-30 4 FORM 4 SUBMISSION 0000899243-22-037231 9760
2022-11-30 4 FORM 4 SUBMISSION 0000899243-22-037230 9765
2022-11-30 4 FORM 4 SUBMISSION 0000899243-22-037228 9884
2022-11-30 4 FORM 4 SUBMISSION 0000899243-22-037224 9814
2022-11-29 8-K 8-K 7.01,9.01 0000950170-22-025764 001-40629 221428547 34 286308 1 1
2022-11-18 8-K 8-K 8.01,9.01 0000950170-22-025413 001-40629 221400608 34 274624 1 1
2022-11-14 8-K 8-K 8.01,9.01 0000950170-22-024772 001-40629 221381139 34 276103 1 1
2022-11-10 10-Q 10-Q 0000950170-22-024197 001-40629 221375139 34 10368343 1 1
2022-11-10 8-K 8-K 2.02,9.01 0000950170-22-024193 001-40629 221375112 34 449403 1 1
2022-10-17 4 FORM 4 SUBMISSION 0001209191-22-053833 10376
2022-10-17 4 FORM 4 SUBMISSION 0001209191-22-053830 10372
2022-10-17 4 FORM 4 SUBMISSION 0001209191-22-053831 10394
2022-10-17 4 FORM 4 SUBMISSION 0001209191-22-053829 10376
2022-10-17 4 FORM 4 SUBMISSION 0001209191-22-053828 10342
2022-10-14 8-K 8-K 5.07 0001193125-22-263021 001-40629 221311881 34 156177 1 1
2022-09-23 4 FORM 4 SUBMISSION 0001209191-22-051131 5563
2022-09-23 3 FORM 3 SUBMISSION 0001209191-22-051130 7642
2022-09-14 4 FORM 4 SUBMISSION 0000899243-22-031059 6177
2022-09-14 3 FORM 3 SUBMISSION 0000899243-22-031056 7896
2022-09-07 8-K 8-K 5.02,9.01 0001193125-22-239512 001-40629 221229960 34 184591 1 1
2022-09-02 DEFA14A DEFA14A 0001193125-22-237190 001-40629 221223290 34 854249
2022-09-02 DEF 14A DEF 14A 0001193125-22-237187 001-40629 221223276 34 391136
2022-08-12 EFFECT xslEFFECTX01/primary_doc.xml S-3,,2022-08-12 16:00:00 9999999995-22-002371 333-266605 221162052 33 1836
2022-08-10 CORRESP filename1.htm 0001193125-22-217258 6695
2022-08-10 4 FORM 4 SUBMISSION 0000899243-22-028203 5544
2022-08-10 4 FORM 4 SUBMISSION 0000899243-22-028202 5557
2022-08-10 4 FORM 4 SUBMISSION 0000899243-22-028201 5551
2022-08-10 3 FORM 3 SUBMISSION 0000899243-22-028200 7651
2022-08-10 3 FORM 3 SUBMISSION 0000899243-22-028199 7638
2022-08-10 3 FORM 3 SUBMISSION 0000899243-22-028198 7655
2022-08-09 UPLOAD filename1.pdf 0000000000-22-008458 40342
2022-08-05 S-3 S-3 0001193125-22-213718 333-266605 221141664 33 1421671
2022-08-05 10-Q 10-Q 0000950170-22-014970 001-40629 221138776 34 9699911 1 1
2022-08-05 8-K 8-K 2.02,9.01 0000950170-22-014957 001-40629 221138731 34 445998 1 1
2022-08-01 8-K 8-K 5.02,9.01 0001193125-22-207610 001-40629 221122671 34 183350 1 1
2022-06-06 8-K 8-K 7.01,9.01 0001193125-22-167954 001-40629 22996777 34 18352296 1 1
2022-05-27 8-K 8-K 8.01,9.01 0000950170-22-010798 001-40629 22971649 34 291515 1 1
2022-05-12 10-Q 10-Q 0000950170-22-009479 001-40629 22915842 34 8608675 1 1
2022-05-12 8-K 8-K 2.02,9.01 0000950170-22-009475 001-40629 22915803 34 482179 1 1
2022-05-10 4 FORM 4 SUBMISSION 0000899243-22-017477 14570
2022-05-10 4 FORM 4 SUBMISSION 0000899243-22-017474 14606
2022-04-15 4 FORM 4 SUBMISSION 0000899243-22-014892 5675
2022-04-15 3 FORM 3 SUBMISSION 0000899243-22-014891 7706
2022-04-12 4 FORM 4 SUBMISSION 0000899243-22-014591 5642
2022-03-29 S-8 S-8 0001193125-22-088290 333-263961 22782190 33 66053
2022-03-29 10-K 10-K 0000950170-22-004857 001-40629 22777563 34 18288702 1 1
2022-03-29 8-K 8-K 2.02,9.01 0000950170-22-004855 001-40629 22777523 34 605442 1 1
2022-03-01 4 FORM 4 SUBMISSION 0000899243-22-008377 6093
2022-03-01 4 FORM 4 SUBMISSION 0000899243-22-008373 6179
2022-03-01 4 FORM 4 SUBMISSION 0000899243-22-008370 6187
2022-03-01 8-K 8-K 1.01,2.03,7.01,9.01 0001193125-22-059898 001-40629 22694077 34 179839 1 1
2022-02-14 5/A FORM 5/A SUBMISSION 0000899243-22-006325 5814
2022-02-14 5 FORM 5 SUBMISSION 0000899243-22-006188 5614
2022-02-14 SC 13G SC 13G 0001104659-22-022979 005-93359 22633441 34 94133
2022-02-14 SC 13D SCHEDULE FILED TO REPORT ACQUISITION OF BENEFICIAL OWNERSHIP 0001387131-22-001918 005-93359 22633340 34 75530
2022-02-14 5 FORM 5 SUBMISSION 0000899243-22-006184 7717
2022-02-09 SC 13G filing.txt 0000315066-22-000944 005-93359 22604240 34 8463
2022-02-09 8-K 8-K 8.01,9.01 0001193125-22-031893 001-40629 22603852 34 171248 1 1
2022-02-07 4 FORM 4 SUBMISSION 0000899243-22-005079 5619
2022-02-07 3 FORM 3 SUBMISSION 0000899243-22-005071 9700
2022-01-31 8-K 8-K 5.02 0001193125-22-022449 001-40629 22571448 34 147666 1 1
2021-11-12 10-Q 10-Q 0000950170-21-004274 001-40629 211399969 34 8359984 1 1
2021-11-12 8-K 8-K 2.02,9.01 0000950170-21-004257 001-40629 211399803 34 431016 1 1
2021-09-08 10-Q 10-Q 0001564590-21-047259 001-40629 211240814 34 7873678 1 1
2021-09-08 8-K 8-K 2.02,9.01 0001193125-21-267324 001-40629 211240748 34 231811 1 1
2021-08-17 8-K 8-K 8.01,9.01 0001193125-21-249224 001-40629 211183297 34 34209
2021-08-04 4/A FORM 4/A SUBMISSION 0000899243-21-031614 14373
2021-08-02 4 FORM 4 SUBMISSION 0000899243-21-031104 14424
2021-08-02 4 FORM 4 SUBMISSION 0000899243-21-031103 13216
2021-08-02 4 FORM 4 SUBMISSION 0000899243-21-031102 9241
2021-08-02 4 FORM 4 SUBMISSION 0000899243-21-031097 9300
2021-08-02 4 FORM 4 SUBMISSION 0000899243-21-031096 13128
2021-08-02 4 FORM 4 SUBMISSION 0000899243-21-031092 4611
2021-08-02 4 FORM 4 SUBMISSION 0000899243-21-031088 13156
2021-08-02 4 FORM 4 SUBMISSION 0000899243-21-031086 9300
2021-07-30 8-K 8-K 5.02,5.03,9.01 0001193125-21-229437 001-40629 211128822 34 150226
2021-07-29 4 FORM 4 SUBMISSION 0000899243-21-030774 11567
2021-07-29 S-8 S-8 0001193125-21-229431 333-258279 211128811 33 85823
2021-07-28 424B4 424B4 0001193125-21-227369 333-257444 211122525 33 6323883
2021-07-26 EFFECT xslEFFECTX01/primary_doc.xml S-1,,2021-07-26 16:00:00 9999999995-21-002918 333-257444 211115787 33 1836
2021-07-26 3 FORM 3 SUBMISSION 0000899243-21-030060 4495
2021-07-26 3 FORM 3 SUBMISSION 0000899243-21-030059 4339
2021-07-26 3 FORM 3 SUBMISSION 0000899243-21-030058 7966
2021-07-26 3 FORM 3 SUBMISSION 0000899243-21-030056 3021
2021-07-26 3 FORM 3 SUBMISSION 0000899243-21-030054 7121
2021-07-26 3 FORM 3 SUBMISSION 0000899243-21-030051 8674
2021-07-26 3 FORM 3 SUBMISSION 0000899243-21-030050 7601
2021-07-26 3 FORM 3 SUBMISSION 0000899243-21-030047 5562
2021-07-26 3 FORM 3 SUBMISSION 0000899243-21-030046 3027
2021-07-26 3 FORM 3 SUBMISSION 0000899243-21-030044 8339

Latest XBRL company facts

One latest value per concept from companyfacts (221 concepts). Full history stays in the JSON.

TaxonomyTagLabelUnitValueStartEndFYFPFormFiledAccn
dei EntityCommonStockSharesOutstanding Entity Common Stock, Shares Outstanding shares 78.45M 2026-11-05 2026 Q3 10-Q 2026-11-12 0001193125-26-458380
dei EntityPublicFloat Entity Public Float USD 245.30M 2025-06-30 2025 FY 10-K 2026-03-12 0001193125-26-103134
us-gaap AccountsPayableCurrent Accounts Payable, Current USD 2.54M 2026-09-30 2026 Q3 10-Q 2026-11-12 0001193125-26-458380
us-gaap AccruedLiabilitiesCurrent Accrued Liabilities, Current USD 7.72M 2026-09-30 2026 Q3 10-Q 2026-11-12 0001193125-26-458380
us-gaap AccruedProfessionalFeesCurrent Accrued Professional Fees, Current USD 876,000 2026-09-30 2026 Q3 10-Q 2026-11-12 0001193125-26-458380
us-gaap AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment Accumulated Depreciation, Depletion and Amortization, Property, Plant, and Equipment USD 3.93M 2026-09-30 2026 Q3 10-Q 2026-11-12 0001193125-26-458380
us-gaap AdditionalPaidInCapitalCommonStock Additional Paid in Capital, Common Stock USD 431.28M 2026-09-30 2026 Q3 10-Q 2026-11-12 0001193125-26-458380
us-gaap AdjustmentsRelatedToTaxWithholdingForShareBasedCompensation Share-based Payment Arrangement, Decrease for Tax Withholding Obligation USD 121,000 2023-01-01 2023-12-31 2024 FY 10-K 2025-03-13 0000950170-25-038803
us-gaap AdjustmentsToAdditionalPaidInCapitalMarkToMarket Adjustments to Additional Paid in Capital, Fair Value USD 692,000 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-12 0001193125-26-458380
us-gaap AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue APIC, Share-based Payment Arrangement, Increase for Cost Recognition USD 6.27M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-12 0001193125-26-458380
us-gaap AllocatedShareBasedCompensationExpense Share-based Payment Arrangement, Expense USD 6.96M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-12 0001193125-26-458380
us-gaap AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount shares 17.10M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-12 0001193125-26-458380
us-gaap Assets Assets USD 211.11M 2026-09-30 2026 Q3 10-Q 2026-11-12 0001193125-26-458380
us-gaap AssetsCurrent Assets, Current USD 207.35M 2026-09-30 2026 Q3 10-Q 2026-11-12 0001193125-26-458380
us-gaap BusinessDevelopment Business Development USD 27.16M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-12 0001193125-26-458380
us-gaap CapitalExpendituresIncurredButNotYetPaid Capital Expenditures Incurred but Not yet Paid USD 125,000 2025-01-01 2025-09-30 2026 Q3 10-Q 2026-11-12 0001193125-26-458380
us-gaap CashAndCashEquivalentsAtCarryingValue Cash and Cash Equivalents, at Carrying Value USD 203.12M 2026-09-30 2026 Q3 10-Q 2026-11-12 0001193125-26-458380
us-gaap CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents USD 203.53M 2026-09-30 2026 Q3 10-Q 2026-11-12 0001193125-26-458380
us-gaap CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect USD 83.39M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-12 0001193125-26-458380
us-gaap CommonStockCapitalSharesReservedForFutureIssuance Common Stock, Capital Shares Reserved for Future Issuance shares 18.85M 2026-09-30 2026 Q3 10-Q 2026-11-12 0001193125-26-458380
us-gaap CommonStockParOrStatedValuePerShare Common Stock, Par or Stated Value Per Share USD/shares 0.01 2026-09-30 2026 Q3 10-Q 2026-11-12 0001193125-26-458380
us-gaap CommonStockSharesAuthorized Common Stock, Shares Authorized shares 150.00M 2026-09-30 2026 Q3 10-Q 2026-11-12 0001193125-26-458380
us-gaap CommonStockSharesIssued Common Stock, Shares, Issued shares 78.57M 2026-09-30 2026 Q3 10-Q 2026-11-12 0001193125-26-458380
us-gaap CommonStockSharesOutstanding Common Stock, Shares, Outstanding shares 78.45M 2026-09-30 2026 Q3 10-Q 2026-11-12 0001193125-26-458380
us-gaap CommonStockValue Common Stock, Value, Issued USD 786,000 2026-09-30 2026 Q3 10-Q 2026-11-12 0001193125-26-458380
us-gaap ComprehensiveIncomeNetOfTax Comprehensive Income (Loss), Net of Tax, Attributable to Parent USD -36.12M 2021-01-01 2021-12-31 2021 FY 10-K 2022-03-29 0000950170-22-004857
us-gaap ConversionOfStockSharesConverted1 Conversion of Stock, Shares Converted shares 7.07M 2021-01-01 2021-12-31 2021 FY 10-K 2022-03-29 0000950170-22-004857
us-gaap DebtInstrumentCarryingAmount Long-term Debt, Gross USD 47.07M 2026-09-30 2026 Q3 10-Q 2026-11-12 0001193125-26-458380
us-gaap DebtInstrumentFaceAmount Debt Instrument, Face Amount USD 50.00M 2026-09-30 2026 Q3 10-Q 2026-11-12 0001193125-26-458380
us-gaap DebtInstrumentUnamortizedDiscount Debt Instrument, Unamortized Discount USD 6.26M 2026-09-30 2026 Q3 10-Q 2026-11-12 0001193125-26-458380
us-gaap DeferredCosts Deferred Costs, Noncurrent USD 0 2021-09-30 2021 Q3 10-Q 2021-11-12 0000950170-21-004274
us-gaap DeferredIncomeTaxLiabilities Deferred Tax Liabilities, Gross USD 438,000 2025-12-31 2025 FY 10-K 2026-03-12 0001193125-26-103134
us-gaap DeferredRentCreditNoncurrent Deferred Rent Credit, Noncurrent USD 894,000 2021-12-31 2022 FY 10-K 2023-03-30 0000950170-23-010760
us-gaap DeferredRevenueNoncurrent Deferred Revenue, Noncurrent USD 22,000 2026-09-30 2026 Q3 10-Q 2026-11-12 0001193125-26-458380
us-gaap DeferredTaxAssetsDeferredIncome Deferred Tax Assets, Deferred Income USD 0 2023-12-31 2023 FY 10-K 2024-03-28 0000950170-24-037637
us-gaap DeferredTaxAssetsGoodwillAndIntangibleAssets Deferred Tax Assets, Goodwill and Intangible Assets USD 362,000 2025-12-31 2025 FY 10-K 2026-03-12 0001193125-26-103134
us-gaap DeferredTaxAssetsGross Deferred Tax Assets, Gross USD 65.71M 2025-12-31 2025 FY 10-K 2026-03-12 0001193125-26-103134
us-gaap DeferredTaxAssetsLiabilitiesNet Deferred Tax Assets, Net USD 0 2025-12-31 2025 FY 10-K 2026-03-12 0001193125-26-103134
us-gaap DeferredTaxAssetsNet Deferred Tax Assets, Net of Valuation Allowance USD 438,000 2025-12-31 2025 FY 10-K 2026-03-12 0001193125-26-103134
us-gaap DeferredTaxAssetsOperatingLossCarryforwards Deferred Tax Assets, Operating Loss Carryforwards USD 37.93M 2025-12-31 2025 FY 10-K 2026-03-12 0001193125-26-103134
us-gaap DeferredTaxAssetsOther Deferred Tax Assets, Other USD 33,000 2025-12-31 2025 FY 10-K 2026-03-12 0001193125-26-103134
us-gaap DeferredTaxAssetsTaxCreditCarryforwards Deferred Tax Assets, Tax Credit Carryforwards USD 7.74M 2025-12-31 2025 FY 10-K 2026-03-12 0001193125-26-103134
us-gaap DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost Deferred Tax Assets, Tax Deferred Expense, Compensation and Benefits, Share-based Compensation Cost USD 1.38M 2025-12-31 2025 FY 10-K 2026-03-12 0001193125-26-103134
us-gaap DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsOther Deferred Tax Assets, Tax Deferred Expense, Reserves and Accruals, Other USD 756,000 2025-12-31 2025 FY 10-K 2026-03-12 0001193125-26-103134
us-gaap DeferredTaxAssetsValuationAllowance Deferred Tax Assets, Valuation Allowance USD 65.27M 2025-12-31 2025 FY 10-K 2026-03-12 0001193125-26-103134
us-gaap DeferredTaxLiabilitiesOther Deferred Tax Liabilities, Other USD 0 2025-12-31 2025 FY 10-K 2026-03-12 0001193125-26-103134
us-gaap Depreciation Depreciation USD 491,000 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-12 0001193125-26-458380
us-gaap DepreciationAndAmortization Depreciation, Depletion and Amortization, Nonproduction USD 600,000 2022-01-01 2022-09-30 2023 Q3 10-Q 2023-11-09 0000950170-23-061566
us-gaap DepreciationDepletionAndAmortization Depreciation, Depletion and Amortization USD 466,000 2023-01-01 2023-06-30 2023 Q2 10-Q 2023-08-10 0000950170-23-040984
us-gaap EarningsPerShareBasic Earnings Per Share, Basic USD/shares -0.98 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-12 0001193125-26-458380
us-gaap EarningsPerShareBasicAndDiluted Earnings Per Share, Basic and Diluted USD/shares -0.03 2022-01-01 2022-03-31 2022 Q1 10-Q 2022-05-12 0000950170-22-009479
us-gaap EarningsPerShareDiluted Earnings Per Share, Diluted USD/shares -0.98 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-12 0001193125-26-458380
us-gaap EffectiveIncomeTaxRateContinuingOperations Effective Income Tax Rate Reconciliation, Percent pure 0 2025-01-01 2025-12-31 2025 FY 10-K 2026-03-12 0001193125-26-103134
us-gaap EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate Effective Income Tax Rate Reconciliation, at Federal Statutory Income Tax Rate, Percent pure 0.21 2025-01-01 2025-12-31 2025 FY 10-K 2026-03-12 0001193125-26-103134
us-gaap EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance Effective Income Tax Rate Reconciliation, Change in Deferred Tax Assets Valuation Allowance, Percent pure 0.267 2025-01-01 2025-12-31 2025 FY 10-K 2026-03-12 0001193125-26-103134
us-gaap EffectiveIncomeTaxRateReconciliationNondeductibleExpenseOther Effective Income Tax Rate Reconciliation, Nondeductible Expense, Other, Percent pure -0.004 2025-01-01 2025-12-31 2025 FY 10-K 2026-03-12 0001193125-26-103134
us-gaap EffectiveIncomeTaxRateReconciliationNondeductibleExpenseShareBasedCompensationCost Effective Income Tax Rate Reconciliation, Nondeductible Expense, Share-based Payment Arrangement, Percent pure -0.001 2025-01-01 2025-12-31 2025 FY 10-K 2026-03-12 0001193125-26-103134
us-gaap EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes Effective Income Tax Rate Reconciliation, State and Local Income Taxes, Percent pure 0.038 2024-01-01 2024-12-31 2024 FY 10-K 2025-03-13 0000950170-25-038803
us-gaap EffectiveIncomeTaxRateReconciliationTaxCredits Effective Income Tax Rate Reconciliation, Tax Credit, Percent pure 0.01 2024-01-01 2024-12-31 2024 FY 10-K 2025-03-13 0000950170-25-038803
us-gaap EffectiveIncomeTaxRateReconciliationTaxCreditsResearch Effective Income Tax Rate Reconciliation, Tax Credit, Research, Percent pure 0.017 2025-01-01 2025-12-31 2025 FY 10-K 2026-03-12 0001193125-26-103134
us-gaap EmployeeRelatedLiabilitiesCurrent Employee-related Liabilities, Current USD 3.40M 2026-09-30 2026 Q3 10-Q 2026-11-12 0001193125-26-458380
us-gaap EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedShareBasedAwardsOtherThanOptions Share-based Payment Arrangement, Nonvested Award, Excluding Option, Cost Not yet Recognized, Amount USD 24.10M 2026-09-30 2026 Q3 10-Q 2026-11-12 0001193125-26-458380
us-gaap FairValueAdjustmentOfWarrants Fair Value Adjustment of Warrants USD 3.77M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-12 0001193125-26-458380
us-gaap GainLossOnDispositionOfAssets1 Gain (Loss) on Disposition of Assets USD -339,000 2025-01-01 2025-09-30 2026 Q3 10-Q 2026-11-12 0001193125-26-458380
us-gaap GeneralAndAdministrativeExpense General and Administrative Expense USD 20.78M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-12 0001193125-26-458380
us-gaap ImpairmentOfLongLivedAssetsHeldForUse Impairment of Long-Lived Assets Held-for-use USD 90,000 2025-01-01 2025-12-31 2025 FY 10-K 2026-03-12 0001193125-26-103134
us-gaap IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic Income (Loss) from Continuing Operations before Income Taxes, Domestic USD -38.18M 2025-01-01 2025-12-31 2025 FY 10-K 2026-03-12 0001193125-26-103134
us-gaap IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest Income (Loss) from Continuing Operations before Income Taxes, Noncontrolling Interest USD -38.18M 2025-01-01 2025-12-31 2025 FY 10-K 2026-03-12 0001193125-26-103134
us-gaap IncomeTaxesPaidNet Income Taxes Paid, Net USD 0 2024-01-01 2024-06-30 2024 Q2 10-Q 2024-08-13 0000950170-24-095784
us-gaap IncomeTaxExpenseBenefit Income Tax Expense (Benefit) USD 0 2025-01-01 2025-12-31 2025 FY 10-K 2026-03-12 0001193125-26-103134
us-gaap IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance Effective Income Tax Rate Reconciliation, Change in Deferred Tax Assets Valuation Allowance, Amount USD -10.22M 2025-01-01 2025-12-31 2025 FY 10-K 2026-03-12 0001193125-26-103134
us-gaap IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate Effective Income Tax Rate Reconciliation at Federal Statutory Income Tax Rate, Amount USD -8.02M 2025-01-01 2025-12-31 2025 FY 10-K 2026-03-12 0001193125-26-103134
us-gaap IncomeTaxReconciliationNondeductibleExpenseOther Effective Income Tax Rate Reconciliation, Nondeductible Expense, Other, Amount USD 149,000 2025-01-01 2025-12-31 2025 FY 10-K 2026-03-12 0001193125-26-103134
us-gaap IncomeTaxReconciliationNondeductibleExpenseShareBasedCompensationCost Effective Income Tax Rate Reconciliation, Nondeductible Expense, Share-based Payment Arrangement, Amount USD 41,000 2025-01-01 2025-12-31 2025 FY 10-K 2026-03-12 0001193125-26-103134
us-gaap IncomeTaxReconciliationTaxCreditsResearch Effective Income Tax Rate Reconciliation, Tax Credit, Research, Amount USD -662,000 2025-01-01 2025-12-31 2025 FY 10-K 2026-03-12 0001193125-26-103134
us-gaap IncreaseDecreaseInAccountsPayable Increase (Decrease) in Accounts Payable USD 1.50M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-12 0001193125-26-458380
us-gaap IncreaseDecreaseInAccruedLiabilities Increase (Decrease) in Accrued Liabilities USD 432,000 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-12 0001193125-26-458380
us-gaap IncreaseDecreaseInContractWithCustomerLiability Increase (Decrease) in Contract with Customer, Liability USD -67,000 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-12 0001193125-26-458380
us-gaap IncreaseDecreaseInOperatingLeaseLiability IncreaseDecreaseInOperatingLeaseLiability USD -333,000 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-12 0001193125-26-458380
us-gaap IncreaseDecreaseInOtherNoncurrentAssets Increase (Decrease) in Other Noncurrent Assets USD -83,000 2021-01-01 2021-12-31 2022 FY 10-K 2023-03-30 0000950170-23-010760
us-gaap IncreaseDecreaseInOtherOperatingAssets Increase (Decrease) in Other Operating Assets USD -28,000 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-12 0001193125-26-458380
us-gaap IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets Increase (Decrease) in Prepaid Expense and Other Assets USD 2.85M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-12 0001193125-26-458380
us-gaap IncrementalCommonSharesAttributableToCallOptionsAndWarrants Incremental Common Shares Attributable to Dilutive Effect of Call Options and Warrants shares 126,924 2025-01-01 2025-06-30 2025 Q2 10-Q 2025-08-14 0000950170-25-108450
us-gaap InterestAndOtherIncome Interest and Other Income USD 4.81M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-12 0001193125-26-458380
us-gaap InterestExpense Interest Expense USD 4.73M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-12 0001193125-26-458380
us-gaap InterestExpenseNonoperating InterestExpenseNonoperating USD 4.73M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-12 0001193125-26-458380
us-gaap InterestIncomeExpenseNet Interest Income (Expense), Net USD 102,000 2023-01-01 2023-03-31 2023 Q1 10-Q 2023-05-11 0000950170-23-020873
us-gaap InterestPaidNet Interest Paid, Excluding Capitalized Interest, Operating Activities USD 3.66M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-12 0001193125-26-458380
us-gaap InvestmentIncomeInterest Investment Income, Interest USD 560,000 2024-01-01 2024-06-30 2024 Q2 10-Q 2024-08-13 0000950170-24-095784
us-gaap InvestmentIncomeNet Investment Income, Net USD -490,000 2022-01-01 2022-12-31 2022 FY 10-K 2023-03-30 0000950170-23-010760
us-gaap LaborAndRelatedExpense Labor and Related Expense USD 8.52M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-12 0001193125-26-458380
us-gaap LeaseAndRentalExpense Operating Leases, Rent Expense USD 476,000 2021-01-01 2021-09-30 2022 Q3 10-Q 2022-11-10 0000950170-22-024197
us-gaap LeaseCost Lease, Cost USD 700,000 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-12 0001193125-26-458380
us-gaap LesseeOperatingLeaseLiabilityPaymentsDue Lessee, Operating Lease, Liability, to be Paid USD 1.82M 2026-09-30 2026 Q3 10-Q 2026-11-12 0001193125-26-458380
us-gaap LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths Lessee, Operating Lease, Liability, to be Paid, Year One USD 613,000 2026-09-30 2026 Q3 10-Q 2026-11-12 0001193125-26-458380
us-gaap LesseeOperatingLeaseLiabilityPaymentsDueYearFour Lessee, Operating Lease, Liability, to be Paid, Year Four USD 426,000 2025-12-31 2025 FY 10-K 2026-03-12 0001193125-26-103134
us-gaap LesseeOperatingLeaseLiabilityPaymentsDueYearThree Lessee, Operating Lease, Liability, to be Paid, Year Three USD 426,000 2026-09-30 2026 Q3 10-Q 2026-11-12 0001193125-26-458380
us-gaap LesseeOperatingLeaseLiabilityPaymentsDueYearTwo Lessee, Operating Lease, Liability, to be Paid, Year Two USD 628,000 2026-09-30 2026 Q3 10-Q 2026-11-12 0001193125-26-458380
us-gaap LesseeOperatingLeaseLiabilityPaymentsRemainderOfFiscalYear Lessee, Operating Lease, Liability, to be Paid, Remainder of Fiscal Year USD 152,000 2026-09-30 2026 Q3 10-Q 2026-11-12 0001193125-26-458380
us-gaap LesseeOperatingLeaseLiabilityUndiscountedExcessAmount Lessee, Operating Lease, Liability, Undiscounted Excess Amount USD 248,000 2026-09-30 2026 Q3 10-Q 2026-11-12 0001193125-26-458380
us-gaap Liabilities Liabilities USD 79.52M 2026-09-30 2026 Q3 10-Q 2026-11-12 0001193125-26-458380
us-gaap LiabilitiesAndStockholdersEquity Liabilities and Equity USD 211.11M 2026-09-30 2026 Q3 10-Q 2026-11-12 0001193125-26-458380
us-gaap LiabilitiesCurrent Liabilities, Current USD 27.39M 2026-09-30 2026 Q3 10-Q 2026-11-12 0001193125-26-458380
us-gaap LineOfCreditFacilityMaximumBorrowingCapacity Line of Credit Facility, Maximum Borrowing Capacity USD 5.00M 2022-12-30 2024 Q3 10-Q 2024-11-14 0000950170-24-126767
us-gaap LongTermDebt Long-term Debt USD 560,000 2021-12-31 2021 FY 10-K 2022-03-29 0000950170-22-004857
us-gaap LongTermDebtCurrent Long-term Debt, Current Maturities USD 0 2025-12-31 2025 FY 10-K 2026-03-12 0001193125-26-103134
us-gaap LongTermDebtMaturitiesRepaymentsOfPrincipalInNextTwelveMonths Long-Term Debt, Maturity, Year One USD 0 2025-12-31 2025 FY 10-K 2026-03-12 0001193125-26-103134
us-gaap LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFive Long-Term Debt, Maturity, Year Five USD 22.02M 2025-12-31 2025 FY 10-K 2026-03-12 0001193125-26-103134
us-gaap LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFour Long-Term Debt, Maturity, Year Four USD 22.05M 2026-09-30 2026 Q3 10-Q 2026-11-12 0001193125-26-458380
us-gaap LongTermDebtMaturitiesRepaymentsOfPrincipalInYearThree Long-Term Debt, Maturity, Year Three USD 24.15M 2026-09-30 2026 Q3 10-Q 2026-11-12 0001193125-26-458380
us-gaap LongTermDebtMaturitiesRepaymentsOfPrincipalInYearTwo Long-Term Debt, Maturity, Year Two USD 3.80M 2026-09-30 2026 Q3 10-Q 2026-11-12 0001193125-26-458380
us-gaap LongTermDebtMaturitiesRepaymentsOfPrincipalRemainderOfFiscalYear Long-Term Debt, Maturity, Remainder of Fiscal Year USD 2.50M 2025-09-30 2025 Q3 10-Q 2025-11-13 0001193125-25-279086
us-gaap LongTermDebtNoncurrent Long-term Debt, Excluding Current Maturities USD 1.73M 2024-12-31 2024 FY 10-K 2025-03-13 0000950170-25-038803
us-gaap LongTermLoansFromBank Loans Payable to Bank, Noncurrent USD 47.07M 2026-09-30 2026 Q3 10-Q 2026-11-12 0001193125-26-458380
us-gaap LossContingencyLossInPeriod Loss Contingency, Loss in Period USD 0 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-12 0001193125-26-458380
us-gaap NetCashProvidedByUsedInFinancingActivities Net Cash Provided by (Used in) Financing Activities USD 142.61M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-12 0001193125-26-458380
us-gaap NetCashProvidedByUsedInInvestingActivities Net Cash Provided by (Used in) Investing Activities USD -885,000 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-12 0001193125-26-458380
us-gaap NetCashProvidedByUsedInOperatingActivities Net Cash Provided by (Used in) Operating Activities USD -58.34M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-12 0001193125-26-458380
us-gaap NetIncomeLoss Net Income (Loss) Attributable to Parent USD -69.64M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-12 0001193125-26-458380
us-gaap NonoperatingGainsLosses Nonoperating Gains (Losses) USD 67,000 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-12 0001193125-26-458380
us-gaap NonoperatingIncomeExpense Nonoperating Income (Expense) USD -3.63M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-12 0001193125-26-458380
us-gaap NumberOfOperatingSegments Number of Operating Segments Segment 1 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-12 0001193125-26-458380
us-gaap NumberOfReportableSegments Number of Reportable Segments Segment 1 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-12 0001193125-26-458380
us-gaap OperatingExpenses Operating Expenses USD 66.01M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-12 0001193125-26-458380
us-gaap OperatingIncomeLoss Operating Income (Loss) USD -66.01M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-12 0001193125-26-458380
us-gaap OperatingLeaseCost Operating Lease, Cost USD 400,000 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-12 0001193125-26-458380
us-gaap OperatingLeaseExpense Operating Lease, Expense USD 500 2021-01-01 2021-12-31 2022 FY 10-K 2023-03-30 0000950170-23-010760
us-gaap OperatingLeaseLiability Operating Lease, Liability USD 1.57M 2026-09-30 2026 Q3 10-Q 2026-11-12 0001193125-26-458380
us-gaap OperatingLeaseLiabilityCurrent Operating Lease, Liability, Current USD 471,000 2026-09-30 2026 Q3 10-Q 2026-11-12 0001193125-26-458380
us-gaap OperatingLeaseLiabilityNoncurrent Operating Lease, Liability, Noncurrent USD 1.10M 2026-09-30 2026 Q3 10-Q 2026-11-12 0001193125-26-458380
us-gaap OperatingLeasePayments Operating Lease, Payments USD 466,000 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-12 0001193125-26-458380
us-gaap OperatingLeaseRightOfUseAsset Operating Lease, Right-of-Use Asset USD 1.38M 2026-09-30 2026 Q3 10-Q 2026-11-12 0001193125-26-458380
us-gaap OperatingLeasesFutureMinimumPaymentsDue Operating Leases, Future Minimum Payments Due USD 2.78M 2021-12-31 2022 Q3 10-Q 2022-11-10 0000950170-22-024197
us-gaap OperatingLeasesFutureMinimumPaymentsDueCurrent Operating Leases, Future Minimum Payments Due, Next Twelve Months USD 567,000 2021-12-31 2022 Q3 10-Q 2022-11-10 0000950170-22-024197
us-gaap OperatingLeasesFutureMinimumPaymentsDueInFiveYears Operating Leases, Future Minimum Payments, Due in Five Years USD 415,000 2021-12-31 2022 Q3 10-Q 2022-11-10 0000950170-22-024197
us-gaap OperatingLeasesFutureMinimumPaymentsDueInFourYears Operating Leases, Future Minimum Payments, Due in Four Years USD 613,000 2021-12-31 2022 Q3 10-Q 2022-11-10 0000950170-22-024197
us-gaap OperatingLeasesFutureMinimumPaymentsDueInThreeYears Operating Leases, Future Minimum Payments, Due in Three Years USD 598,000 2021-12-31 2022 Q3 10-Q 2022-11-10 0000950170-22-024197
us-gaap OperatingLeasesFutureMinimumPaymentsDueInTwoYears Operating Leases, Future Minimum Payments, Due in Two Years USD 583,000 2021-12-31 2022 Q3 10-Q 2022-11-10 0000950170-22-024197
us-gaap OperatingLeaseWeightedAverageDiscountRatePercent Operating Lease, Weighted Average Discount Rate, Percent pure 0.105 2026-09-30 2026 Q3 10-Q 2026-11-12 0001193125-26-458380
us-gaap OtherAccruedLiabilitiesCurrent Other Accrued Liabilities, Current USD 450,000 2026-09-30 2026 Q3 10-Q 2026-11-12 0001193125-26-458380
us-gaap OtherAssets Other Assets USD 59,000 2026-09-30 2026 Q3 10-Q 2026-11-12 0001193125-26-458380
us-gaap OtherAssetsNoncurrent Other Assets, Noncurrent USD 424,000 2021-12-31 2021 FY 10-K 2022-03-29 0000950170-22-004857
us-gaap OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax OCI, Debt Securities, Available-for-Sale, Unrealized Holding Gain (Loss), before Adjustment, after Tax USD 19,000 2020-01-01 2020-12-31 2021 FY 10-K 2022-03-29 0000950170-22-004857
us-gaap OtherGeneralAndAdministrativeExpense Other General and Administrative Expense USD 2.07M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-12 0001193125-26-458380
us-gaap OtherLiabilitiesCurrent Other Liabilities, Current USD 89,000 2026-09-30 2026 Q3 10-Q 2026-11-12 0001193125-26-458380
us-gaap OtherLongTermDebtNoncurrent Other Long-term Debt, Noncurrent USD 1.13M 2026-09-30 2026 Q3 10-Q 2026-11-12 0001193125-26-458380
us-gaap OtherResearchAndDevelopmentExpense Other Research and Development Expense USD 1.55M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-12 0001193125-26-458380
us-gaap PaymentsOfDebtIssuanceCosts Payments of Debt Issuance Costs USD 178,000 2025-01-01 2025-09-30 2026 Q3 10-Q 2026-11-12 0001193125-26-458380
us-gaap PaymentsOfStockIssuanceCosts Payments of Stock Issuance Costs USD 6.50M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-12 0001193125-26-458380
us-gaap PaymentsRelatedToTaxWithholdingForShareBasedCompensation Payment, Tax Withholding, Share-based Payment Arrangement USD 121,000 2023-01-01 2023-12-31 2024 FY 10-K 2025-03-13 0000950170-25-038803
us-gaap PaymentsToAcquireAvailableForSaleSecuritiesDebt Payments to Acquire Debt Securities, Available-for-sale USD 6,000 2020-01-01 2020-12-31 2021 FY 10-K 2022-03-29 0000950170-22-004857
us-gaap PaymentsToAcquirePropertyPlantAndEquipment Payments to Acquire Property, Plant, and Equipment USD 885,000 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-12 0001193125-26-458380
us-gaap PreferredStockParOrStatedValuePerShare Preferred Stock, Par or Stated Value Per Share USD/shares 0.01 2026-09-30 2026 Q3 10-Q 2026-11-12 0001193125-26-458380
us-gaap PreferredStockSharesAuthorized Preferred Stock, Shares Authorized shares 10.00M 2026-09-30 2026 Q3 10-Q 2026-11-12 0001193125-26-458380
us-gaap PreferredStockSharesIssued Preferred Stock, Shares Issued shares 0 2026-09-30 2026 Q3 10-Q 2026-11-12 0001193125-26-458380
us-gaap PreferredStockSharesOutstanding Preferred Stock, Shares Outstanding shares 0 2026-09-30 2026 Q3 10-Q 2026-11-12 0001193125-26-458380
us-gaap PrepaidExpenseAndOtherAssetsCurrent Prepaid Expense and Other Assets, Current USD 4.24M 2026-09-30 2026 Q3 10-Q 2026-11-12 0001193125-26-458380
us-gaap ProceedsFromBankDebt Proceeds from Bank Debt USD 19.91M 2022-01-01 2022-12-31 2023 FY 10-K 2024-03-28 0000950170-24-037637
us-gaap ProceedsFromIssuanceInitialPublicOffering Proceeds from Issuance Initial Public Offering USD 71.33M 2021-01-01 2021-12-31 2022 FY 10-K 2023-03-30 0000950170-23-010760
us-gaap ProceedsFromIssuanceOfCommonStock Proceeds from Issuance of Common Stock USD 5.04M 2025-01-01 2025-09-30 2025 Q3 10-Q 2025-11-13 0001193125-25-279086
us-gaap ProceedsFromIssuanceOfDebt Proceeds from Issuance of Debt USD 47.95M 2025-01-01 2025-12-31 2025 FY 10-K 2026-03-12 0001193125-26-103134
us-gaap ProceedsFromSaleAndMaturityOfAvailableForSaleSecurities Proceeds from Sale and Maturity of Debt Securities, Available-for-sale USD 39.94M 2020-01-01 2020-12-31 2021 FY 10-K 2022-03-29 0000950170-22-004857
us-gaap ProceedsFromSaleOfAvailableForSaleSecuritiesDebt Proceeds from Sale of Debt Securities, Available-for-sale USD 19.30M 2020-01-01 2020-09-30 2021 Q3 10-Q 2021-11-12 0000950170-21-004274
us-gaap ProceedsFromSaleOfPropertyPlantAndEquipment Proceeds from Sale of Property, Plant, and Equipment USD 27,000 2025-01-01 2025-09-30 2026 Q3 10-Q 2026-11-12 0001193125-26-458380
us-gaap ProceedsFromStockOptionsExercised Proceeds from Stock Options Exercised USD 619,000 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-12 0001193125-26-458380
us-gaap ProceedsFromWarrantExercises Proceeds from Warrant Exercises USD 430,000 2021-01-01 2021-12-31 2022 FY 10-K 2023-03-30 0000950170-23-010760
us-gaap ProfessionalFees Professional Fees USD 4.48M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-12 0001193125-26-458380
us-gaap ProfitLoss Net Income (Loss), Including Portion Attributable to Noncontrolling Interest USD -69.64M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-12 0001193125-26-458380
us-gaap PropertyPlantAndEquipmentGross Property, Plant and Equipment, Gross USD 5.83M 2026-09-30 2026 Q3 10-Q 2026-11-12 0001193125-26-458380
us-gaap PropertyPlantAndEquipmentNet Property, Plant and Equipment, Net USD 1.90M 2026-09-30 2026 Q3 10-Q 2026-11-12 0001193125-26-458380
us-gaap ResearchAndDevelopmentExpense Research and Development Expense USD 45.23M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-12 0001193125-26-458380
us-gaap RestrictedCash Restricted Cash USD 400,000 2026-09-30 2026 Q3 10-Q 2026-11-12 0001193125-26-458380
us-gaap RestrictedCashNoncurrent Restricted Cash, Noncurrent USD 416,000 2026-09-30 2026 Q3 10-Q 2026-11-12 0001193125-26-458380
us-gaap RestructuringAndRelatedCostNumberOfPositionsEliminatedPeriodPercent Restructuring and Related Cost, Number of Positions Eliminated, Period Percent pure 0.45 2023-11-01 2023-11-30 2024 FY 10-K 2025-03-13 0000950170-25-038803
us-gaap RestructuringCosts Restructuring Costs USD 700,000 2023-01-01 2023-12-31 2024 FY 10-K 2025-03-13 0000950170-25-038803
us-gaap RetainedEarningsAccumulatedDeficit Retained Earnings (Accumulated Deficit) USD -300.03M 2026-09-30 2026 Q3 10-Q 2026-11-12 0001193125-26-458380
us-gaap RevenueFromContractWithCustomerExcludingAssessedTax Revenue from Contract with Customer, Excluding Assessed Tax USD 125,000 2022-01-01 2022-12-31 2023 FY 10-K 2024-03-28 0000950170-24-037637
us-gaap RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability Right-of-Use Asset Obtained in Exchange for Operating Lease Liability USD 2.37M 2022-01-01 2022-12-31 2023 FY 10-K 2024-03-28 0000950170-24-037637
us-gaap SeveranceCosts1 Severance Costs USD 700,000 2023-11-01 2023-11-30 2024 FY 10-K 2025-03-13 0000950170-25-038803
us-gaap ShareBasedCompensation Share-based Payment Arrangement, Noncash Expense USD 6.96M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-12 0001193125-26-458380
us-gaap ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExercisePrice Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Exercise Price USD/shares 1.55 2020-06-30 2021 Q2 10-Q 2021-09-08 0001564590-21-047259
us-gaap ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Expected Dividend Rate pure 0 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-12 0001193125-26-458380
us-gaap ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Expected Volatility Rate pure 0.883 2021-01-01 2021-03-31 2022 Q1 10-Q 2022-05-12 0000950170-22-009479
us-gaap ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMaximum Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Expected Volatility Rate, Maximum pure 1.207 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-12 0001193125-26-458380
us-gaap ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMinimum Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Expected Volatility Rate, Minimum pure 1.161 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-12 0001193125-26-458380
us-gaap ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Risk Free Interest Rate pure 0.011 2021-01-01 2021-03-31 2022 Q1 10-Q 2022-05-12 0000950170-22-009479
us-gaap ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMaximum Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Risk Free Interest Rate, Maximum pure 0.051 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-12 0001193125-26-458380
us-gaap ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMinimum Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Risk Free Interest Rate, Minimum pure 0.036 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-12 0001193125-26-458380
us-gaap ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant Share-based Compensation Arrangement by Share-based Payment Award, Number of Shares Available for Grant shares 1.40M 2026-09-30 2026 Q3 10-Q 2026-11-12 0001193125-26-458380
us-gaap SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1 Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercisable, Intrinsic Value USD 33.28M 2026-09-30 2026 Q3 10-Q 2026-11-12 0001193125-26-458380
us-gaap ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercisable, Number shares 4.88M 2026-09-30 2026 Q3 10-Q 2026-11-12 0001193125-26-458380
us-gaap ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercisable, Weighted Average Exercise Price USD/shares 3.63 2026-09-30 2026 Q3 10-Q 2026-11-12 0001193125-26-458380
us-gaap ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriod Share-based Compensation Arrangement by Share-based Payment Award, Options, Forfeitures and Expirations in Period shares 94,945 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-12 0001193125-26-458380
us-gaap ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriodWeightedAverageExercisePrice Share-based Compensation Arrangement by Share-based Payment Award, Options, Forfeitures and Expirations in Period, Weighted Average Exercise Price USD/shares 5.56 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-12 0001193125-26-458380
us-gaap ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Gross shares 3.16M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-12 0001193125-26-458380
us-gaap SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedNumberOfShares Share-based Compensation Arrangement by Share-based Payment Award, Options, Nonvested, Number of Shares shares 4.18M 2026-09-30 2026 Q3 10-Q 2026-11-12 0001193125-26-458380
us-gaap SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedOptionsForfeitedWeightedAverageGrantDateFairValue Share-based Compensation Arrangement by Share-based Payment Award, Options, Nonvested Options Forfeited, Weighted Average Grant Date Fair Value USD/shares 7 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-12 0001193125-26-458380
us-gaap ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Intrinsic Value USD 47.89M 2026-09-30 2026 Q3 10-Q 2026-11-12 0001193125-26-458380
us-gaap ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Number shares 9.06M 2026-09-30 2026 Q3 10-Q 2026-11-12 0001193125-26-458380
us-gaap ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Weighted Average Exercise Price USD/shares 5.18 2026-09-30 2026 Q3 10-Q 2026-11-12 0001193125-26-458380
us-gaap ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableAggregateIntrinsicValue Share-based Compensation Arrangement by Share-based Payment Award, Options, Vested and Expected to Vest, Exercisable, Aggregate Intrinsic Value USD 2.30M 2026-09-30 2026 Q3 10-Q 2026-11-12 0001193125-26-458380
us-gaap ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingAggregateIntrinsicValue Share-based Compensation Arrangement by Share-based Payment Award, Options, Vested and Expected to Vest, Outstanding, Aggregate Intrinsic Value USD 3.70M 2024-09-30 2024 Q3 10-Q 2024-11-14 0000950170-24-126767
us-gaap SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedInPeriodFairValue1 Share-based Compensation Arrangement by Share-based Payment Award, Options, Vested in Period, Fair Value USD 4,970 2021-01-01 2021-03-31 2022 Q1 10-Q 2022-05-12 0000950170-22-009479
us-gaap ShareBasedCompensationArrangementByShareBasedPaymentAwardSharesIssuedInPeriod Share-based Compensation Arrangement by Share-based Payment Award, Shares Issued in Period shares 5.34M 2021-06-14 2021 Q2 10-Q 2021-09-08 0001564590-21-047259
us-gaap ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice Share-based Compensation Arrangements by Share-based Payment Award, Options, Exercises in Period, Weighted Average Exercise Price USD/shares 2.46 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-12 0001193125-26-458380
us-gaap ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice Share-based Compensation Arrangements by Share-based Payment Award, Options, Grants in Period, Weighted Average Exercise Price USD/shares 6.89 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-12 0001193125-26-458380
us-gaap StockholdersEquity Stockholders' Equity Attributable to Parent USD 131.59M 2026-09-30 2026 Q3 10-Q 2026-11-12 0001193125-26-458380
us-gaap StockholdersEquityNoteStockSplitConversionRatio1 Stockholders' Equity Note, Stock Split, Conversion Ratio pure 0.407 2021-07-14 2021 FY 10-K 2022-03-29 0000950170-22-004857
us-gaap StockIssuedDuringPeriodSharesStockOptionsExercised Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercises in Period shares 251,124 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-12 0001193125-26-458380
us-gaap StockIssuedDuringPeriodValueNewIssues Stock Issued During Period, Value, New Issues USD 48.24M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-12 0001193125-26-458380
us-gaap StockIssuedDuringPeriodValueStockOptionsExercised Stock Issued During Period, Value, Stock Options Exercised USD 619,000 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-12 0001193125-26-458380
us-gaap TangibleAssetImpairmentCharges Tangible Asset Impairment Charges USD 83,000 2025-01-01 2025-09-30 2026 Q3 10-Q 2026-11-12 0001193125-26-458380
us-gaap TemporaryEquityCarryingAmountAttributableToParent Temporary Equity, Carrying Amount, Attributable to Parent USD 0 2021-09-30 2022 Q3 10-Q 2022-11-10 0000950170-22-024197
us-gaap TemporaryEquitySharesAuthorized Temporary Equity, Shares Authorized shares 17.19M 2020-12-31 2021 FY 10-K 2022-03-29 0000950170-22-004857
us-gaap TreasuryStockValue Treasury Stock, Value USD 448,000 2026-09-30 2026 Q3 10-Q 2026-11-12 0001193125-26-458380
us-gaap TreasuryStockValueAcquiredCostMethod Treasury Stock, Value, Acquired, Cost Method USD 448,000 2022-01-01 2022-12-31 2023 FY 10-K 2024-03-28 0000950170-24-037637
us-gaap VariableLeaseCost Variable Lease, Cost USD 300,000 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-12 0001193125-26-458380
us-gaap WeightedAverageNumberDilutedSharesOutstandingAdjustment Weighted Average Number Diluted Shares Outstanding Adjustment shares 0 2026-01-01 2026-06-30 2026 Q2 10-Q 2026-08-13 0001193125-26-347980
us-gaap WeightedAverageNumberOfDilutedSharesOutstanding Weighted Average Number of Shares Outstanding, Diluted shares 71.35M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-12 0001193125-26-458380
us-gaap WeightedAverageNumberOfShareOutstandingBasicAndDiluted Weighted Average Number of Shares Outstanding, Basic and Diluted shares 28.69M 2022-01-01 2022-03-31 2022 Q1 10-Q 2022-05-12 0000950170-22-009479
us-gaap WeightedAverageNumberOfSharesOutstandingBasic Weighted Average Number of Shares Outstanding, Basic shares 71.35M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-12 0001193125-26-458380

Financialist News Desk

Our desk turns official SEC filings into news. Each story is checked against the original filing. About us → · Editorial standards →